THC · XBRL financial data
Tenet Healthcare financial statements, every fiscal year
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (THC's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 17,640 | 19,485 | 19,174 | 20,548 | 20,665 | 21,310 |
| Operating income (loss) | 1,989 | 2,871 | 2,333 | 2,510 | 5,956 | 3,508 |
| Interest expense | 1,003 | 923 | 890 | 901 | 826 | 821 |
| Other income (expense) | 1 | 14 | 10 | 19 | 126 | 117 |
| Income tax expense (benefit) | (97) | 411 | 344 | 306 | 1,184 | 433 |
| Earnings per share, basic USD per share | 3.80 | 8.55 | 3.84 | 6.01 | 33.02 | 15.61 |
| Earnings per share, diluted USD per share | 3.75 | 8.42 | 3.79 | 5.71 | 32.70 | 15.49 |
| Weighted average shares, basic millions of shares | 105 | 107 | 107 | 102 | 97 | 90 |
| Weighted average shares, diluted millions of shares | 106 | 109 | 111 | 105 | 98 | 91 |
Balance sheet
CSVFiscal years (THC's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 2,446 | 2,364 | 858 | 1,228 | 3,019 | 2,883 |
| Marketable securities, non-current | 3 | 9 | 30 | 48 | 50 | 59 |
| Accounts receivable | 2,690 | 2,770 | 2,943 | 2,914 | 2,536 | 2,565 |
| Inventory | 368 | 384 | 405 | 411 | 346 | 348 |
| Total current assets | 7,147 | 7,075 | 5,981 | 7,167 | 7,682 | 7,849 |
| Right-of-use asset | 1,062 | 1,002 | 1,129 | 1,083 | 1,037 | 1,134 |
| Goodwill | 8,808 | 9,261 | 10,123 | 10,307 | 10,691 | 11,198 |
| Total assets | 27,106 | 27,579 | 27,156 | 28,312 | 28,936 | 29,677 |
| Accounts payable | 1,207 | 1,300 | 1,504 | 1,408 | 1,294 | 1,360 |
| Total current liabilities | 4,847 | 5,109 | 4,476 | 4,760 | 4,310 | 4,463 |
| Lease liability, non-current | 999 | 924 | 1,046 | 1,007 | 950 | 1,043 |
| Total liabilities | 24,217 | 23,322 | 22,548 | 22,804 | 20,389 | 20,704 |
| Retained earnings (accumulated deficit) | (2,128) | (1,214) | (803) | (192) | 3,008 | 4,415 |
| Total stockholders' equity | 28 | 1,028 | 1,142 | 1,608 | 4,171 | 4,220 |
| Total liabilities and equity | 27,106 | 27,579 | 27,156 | 28,312 | 28,936 | 29,677 |
| Common shares outstanding (cover page) millions of shares | 106 | 107 | 102 | 100 | 95 | 87 |
Cash flows
CSVFiscal years (THC's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Stock-based compensation | 44 | 56 | 56 | 66 | 67 | 104 |
| Depreciation and amortization | 857 | 855 | 841 | 870 | 818 | 863 |
| Net cash from operating activities | 3,407 | 1,568 | 1,083 | 2,374 | 2,047 | 3,540 |
| Purchases of property and equipment | 540 | 658 | 762 | 751 | 931 | 1,010 |
| Net cash from investing activities | (1,608) | (714) | (808) | (969) | 3,429 | (1,275) |
| Share repurchases | 0 | 0 | 250 | 200 | 672 | 1,386 |
| Net cash from financing activities | 385 | (936) | (1,781) | (1,035) | (3,685) | (2,401) |
| Net change in cash | 2,184 | (82) | (1,506) | 370 | 1,791 | (136) |
Compare with peers
SIC 8062 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8062 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Quarter |
|---|---|---|---|---|---|
| Tenet Healthcare | 2,674 | 5,631 | 1,281* | 79.6M | 10-QSep 30, 2026 |
| Encompass Health | 76 | 1,610 | 362* | 98.1M | 10-QSep 30, 2026 |
| Universal Health Services | 139 | 4,638 | 443* | not reported | 10-QJun 30, 2026 |
| Surgery Partners | 217 | not reported | 59* | 130.9M | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.
